Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 2/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526046 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3804 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL15751 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL43221 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685975 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2119135 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL119680 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16041 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL62799 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL14696035 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023160458-A1 | CHINESE HERBAL MEDICINE ACTIVE SUBSTANCE @ VESICLE COMPLEX HAVING HAIR CARE AND GROWTH EFFECTS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 山东大学 | 2023-08-31 | — | — | WO | claimed |
| US-20130309282-A1 | HAIRSTYLING AGENT COMPOSITION | KIKUBOSHI CORPORATION (JP) | 2013-11-21 | — | — | US | claimed |
| WO-2007046577-A1 | EXTERNAL COMPOSITION FOR HAIR GROWTH | AMOREPACIFIC CORPORATION (KR) | 2007-04-26 | — | — | WO | claimed |
| EP-4729623-A1 | SUBSTANCE AND METHOD FOR IMPROVING INTESTINAL HEALTH AND HOMEOSTASIS, AND NUTRITION AND DEVELOPMENT OF SUBJECT | Wilmar (shanghai) Biotechnology Research & Development Center Co., Ltd. (CN) | 2026-04-22 | — | — | EP | disclosed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4592333-A1 | RESIN PARTICLES AND USE THEREOF | Sekisui Kasei Co., Ltd. (JP) | 2025-07-30 | — | — | EP | disclosed |
| US-20250223497-A1 | WELLBORE FLUIDS INCLUDING EMULSIFIER COMPOSITIONS, AND RELATED METHODS OF OPERATING A WELLBORE AND FORMING THE EMULSIFIER COMPOSITIONS | SCHLUMBERGER TECHNOLOGY CORPORATION | 2025-07-10 | — | — | US | disclosed |
| WO-2025110244-A1 | NOVEL COMPOUND AND USE THEREOF | オリザ油化株式会社 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025085434-A1 | FORMULATIONS TO RESTORE AND ENHANCE THE SKIN BARRIER | COLORESCIENCE, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-12257335-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-25 | — | — | US | disclosed |
| EP-1496889-B1 | STABILIZED ASCORBIC ACID DERIVATIVES | SHOWA DENKO KK (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-20050118121-A1 | Cosmetics | KANEBO COSMETICS INC. (JP) | 2005-06-02 | — | — | US | disclosed |
| EP-1496889-A1 | STABILIZED ASCORBIC ACID DERIVATIVES | Showa Denko K.K. (JP) | 2005-01-19 | — | — | EP | disclosed |
| US-20040202627-A1 | Cometics and makeup method | KAO CORPORATION (JP) | 2004-10-14 | — | — | US | disclosed |
| EP-1415639-A1 | COMETICS AND MAKEUP METHOD | Kanebo, Limited (JP) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003086384-A1 | STABILIZED ASCORBIC ACID DERIVATIVES | SHOWA DENKO K. K. (JP) | 2003-10-23 | — | — | WO | disclosed |
| EP-1327442-A1 | PROCESS FOR PRODUCING GEL SHEET FOR APPLICATION TO LIVING BODY, GEL SHEET FOR APPLICATION TO LIVING BODY OBTAINED BY THE PRODUCTION PROCESS, AND METHOD OF SKIN CARE WITH THE SAME | Sekisui Kaseihin Kogyo Kabushiki Kaisha (JP) | 2003-07-16 | — | — | EP | disclosed |
| EP-1213006-A1 | COSMETICS | KANEBO, LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |
| CN-1101209-A | Shutter for cartridges for disks or tapes of excellent printability | ASAHI CHEMICAL IND (JP) | 1995-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050118121-A1 | Cosmetics | CUTA, MC1R, MITF | LMNA 1404/4885KDM4E 1601/4885DUSP3 4559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.